Join

Compare · RBOT vs SNN

RBOT vs SNN

Side-by-side comparison of Vicarious Surgical Inc. (RBOT) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both RBOT and SNN operate in Industrial Specialties (Health Care), so they compete in similar markets.
  • SNN is the larger of the two at $13.14B, about 18.4x RBOT ($714.1M).
  • Over the past year, RBOT is down 77.0% and SNN is up 9.7% - SNN leads by 86.7 points.
  • SNN has been more active in the news (7 items in the past 4 weeks vs 4 for RBOT).
  • SNN has more recent analyst coverage (22 ratings vs 6 for RBOT).
PerformanceRBOT-77.03%SNN+8.22%
2025-05-01+0.00%2026-04-29
MetricRBOTSNN
Company
Vicarious Surgical Inc.
Smith & Nephew SNATS Inc.
Price
$1.99-0.75%
$30.94+1.88%
Market cap
$714.1M
$13.14B
1M return
+0.00%
-2.70%
1Y return
-77.03%
+9.68%
Industry
Industrial Specialties
Industrial Specialties
Exchange
NYSE
NYSE
IPO
2020
News (4w)
4
7
Recent ratings
6
22
RBOT

Vicarious Surgical Inc.

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

SNN

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Latest RBOT

Latest SNN